According to a new research report “Ewing sarcoma Therapeutics Pipeline Analysis, 2017 – Clinical Trials & Results, Patent, Designation, Collaboration and Other Developments” published by P&S Market Research, Ewing sarcoma currently exhibits a strong pipeline with approximately 29 drug candidates.
Explore Report Description at: https://www.psmarketresearch.com/market-analysis/ewing-sarcoma-therapeutics-pipeline-analysis
Ewing sarcoma pipeline comprises approximately 29 drug candidates in different stages of development. Ewing sarcoma is a condition in which formation of cancer or tumor takes place in bones and soft tissues. The symptoms associated with Ewing sarcoma include pain as well as swelling in the chest, back, legs, pelvis and arms, lumps in arms, bone fracture, weight loss, loss of appetite, fatigue, malaise, etc.
The pipeline for Ewing sarcoma was analyzed based on the route of administration and it was found that most of the drug candidates are being developed to be administered by oral route.
The research also found that various companies are engaged in collaborations for Ewing sarcoma. In April 2014, NanoSmart Pharmaceuticals Inc. and NanoValent Pharmaceuticals Inc., entered into a research collaboration agreement to find out the feasibility of jointly developing an ANA-conjugated liposomal doxorubicin nanoparticle for the treatment of ovarian cancer and other solid tumors.
Novel technologies are being used for Ewing sarcoma drug candidates. MacroGenics Inc., has been using Fc Optimization platform for the development of their drug candidates.
Some of the key players developing Ewing sarcoma therapeutics include Celgene Corporation, Pfizer Inc., and Novartis AG, and others.
About P&S Market Research
P&S Market Research is a market research company, which offers market research and consulting services for various geographies around the globe. We provide market research reports, industry forecasting reports, business intelligence, and research based consulting services across different industry/business verticals.
As one of the top growing market research agency, we’re keen upon providing market landscape and accurate forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through their interaction with leading companies of the concerned domain. We help our clients with B2B market research and assist them in identifying various windows of opportunity, and framing informed and customized business expansion strategies in different regions.
Manager – Client Partner
347, 5th Ave. #1402
New York City, NY – 10016
Toll-Free: +1-888-778-7886 (USA/Canada)